Clinical Trial Detail

NCT ID NCT04038502
Title BRcA Deficient Prostate Cancer Treated With Carboplatin or Docetaxel
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors VA Office of Research and Development
Indications

prostate cancer

Therapies

Carboplatin

Docetaxel

Age Groups: adult senior

No variant requirements are available.